Travelers Companies Q2 Adj. EPS $10.04 Beats $5.38 Estimate, Sales $12.153B Beat $11.346B Estimate
Travelers Companies Q2 Adj. EPS $10.04 Beats $5.38 Estimate, Sales $12.153B Beat $11.346B Estimate
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Travelers Companies Q2 Adj. EPS $10.04 Beats $5.38 Estimate, Sales $12.153B Beat $11.346B Estimate
Earnings Scheduled For July 17, 2026
What's Going on With Apple Stock Friday?
Abbott To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Friday
This 3M Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Ex-Intel CEO Warns China-Induced Taiwan Blackout Could Trigger a Crisis Worse Than the Great Depression: 'When You Turn Off a Fab...'
Jim Cramer Says Microchip Is Near A Bottom — 'I Don't See It Yet' — While Nebius Is 'Not Done Going Down'
Guggenheim Reiterates Buy on Johnson & Johnson, Maintains $270 Price Target
UBS Maintains Buy on UnitedHealth Group, Raises Price Target to $490
Apple, Micron, Rocket Companies And More On CNBC’s ‘Final Trades’
'Apple Hunts for AI Chip Acquisitions' - The Information
Chip Stocks' Worst Month Ever Versus Software: Is the AI Trade Cracking?
RBC Capital Maintains Outperform on UnitedHealth Group, Raises Price Target to $478
Truist Securities Maintains Buy on UnitedHealth Group, Raises Price Target to $500
UnitedHealth Analysts Increase Their Forecasts After Better-Than-Expected Q2 Results
Evercore ISI Group Maintains Outperform on Goldman Sachs Group, Raises Price Target to $1210
Evercore ISI Group Maintains Outperform on JPMorgan Chase, Raises Price Target to $368
Apple's Market Capitalization Rises Above Nvidia, Regains Title As Most Valuable U.S. Public Traded Co.
Why UnitedHealth Can't Stop Saying One Word: 'Restless'
Travelers Companies shares are trading higher after the company reported better-than-expected Q2 financial results.